Notably, in BRCA, diffuse large B-cell lymphoma (DLBC), and LUAD, high GCKR expression predicted unfavorable outcomes, whereas in gastric cancer, reduced GCKR expression was correlated with poorer prognosis (Figure 5c). Here, GCKR is linked to diffuse large B-cell lymphoma.